Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold

International Journal of General Medicine

Volumn 4, Issue , 2011, Pages 45-51

  Yakoot, Mostafa ^a   Salem, Amel ^b  

^a Green Clinic   (Egypt)

^b Mabbarah Hospital   (Egypt)

Author keywords

Common cold; Immumax; Multiherbal

Indexed keywords

ASCORBIC ACID; ECHINACEA EXTRACT; ESSENTIAL OIL; GINSENG EXTRACT; HERBACEOUS AGENT; IMMUMAX; PLACEBO; UNCLASSIFIED DRUG; ZINC;

ABDOMINAL PAIN; ADULT; ARTICLE; BLACK CUMIN; COMMON COLD; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GARLIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VOMITING;

EID: 84897367552     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S16266     Document Type: Article

References (46)

1. Kirkpatrick GL. The common cold. Prim Care. 1996;23:657-675.
2. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531-539.
3. Engel JP. Viral upper respiratory infections. Semin Respir Infect. 1995; 10:3-13.
4. Lowenstein SR, Parrino TA. Management of the common cold. Adv Intern Med. 1987;32:207-233.
5. Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect. 1993;111:143-156.
6. Gwaltney JM Jr. Rhinovirus infection of the normal human airway. Am J Respir Crit Care Med. 1995;152(2):S36-S39.
7. Lorber B. The common cold. J Gen Intern Med. 1996;11:229-236.
8. Mossad SB. Treatment of the common cold. BMJ. 1998;317:33-36.
9. Chichon PG. Herbs and the common cold. Adv Nurse Pract. 2000;8: 31-32.
10. Pepping J. Echinacea. Am J Health Syst Pharm. 1999;56:121-122.
11. Giles JT, Palat CT 3rd, Chien SH, Chang ZG, Kennedy DT. Evaluation of Echinacea for treatment of the common cold. Pharmacotherapy. 2000;20:690-697.
12. Blumenthal M, Riggins C. Popular Herbs in the US Market: Therapeutic Monographs. Austin, Texas: American Botanical Council; 1997:1-68.
13. Blumenthal M. The Complete German Commission E Monographs. Boston, Mass: Integrative Medicine Communications; 1998.
14. Hoheisel O, Sandberg M, Bertram S, Bulitta M, Schäfer M. Echinagard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur J Clin Res. 1997;9:261-268.
15. Schulten B, Bulitta M, Ballering-Bruhl B, Koster U, Schafer M. Efficacy of Echinacea purpurea in patients with a common cold: a placebocontrolled, randomised, double-blind clinical trial. Arzneimittelforschung. 2001;51:563-568.
16. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled, randomized trial. Arch Fam Med. 1998;7:541-545.
17. Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Altern Complement Med. 1995;1:145-160.
18. Block E. The chemistry of garlic and onions. Sci Am. 1985;252: 114-119.
19. Imai J, Ide N, Nagae S, Moriguchi T, Matsuura H, Itakura Y. Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med. 1994;60:17-20.
20. O'Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol. 2000;66:2269-2273.
21. Tsao S, Yin M. In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother. 2001;47:665-670.
22. Corzo-Martinez M, Corzo N, Villamiel M. Biological properties of onions and garlic. Trends Food Sci Technol. 2007;18:609-625.
23. Caragay AB. Cancer-preventive foods and ingredients. Food Technol. 1992;4:65-68.
24. Attar-ur-Rahman, Malik S, Cunheng H, Clardy J. Isolation and structure of determination of nigellicine, a novel alkaloid from the seeds of Nigella sativa. Tetrahedron Lett. 1985;26:2759-2762.
25. El-Kadi, Kandil O. The 1st International Conference on Scientific Miracles of Quran and Sunnah, Islamabad, Pakistan. 1987.
26. Hanafy MSM, Hatem ME. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J Ethnopharmacol.1991;34:275-278.
27. Wang M, Guilbert LJ, Ling L, Li J, Wu Y, Xu S, et al. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J Pharm Pharmacol. 2001; 53:1515-1523.
28. Tomoda M, Hirabayashi K, Shimizu N, Gonda R, Ohara N, Takada K. Characterization of two novel polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull. 1993;16:1087-1090.
29. Shin KS, Kiyohara H, Matsumo T, Yamada H. Rhamnogalactouronan II from the leaves of Panax ginseng C.A. Meyer as macophage Fcreceptor expression enhancing polysaccharide. Carbohydr Res. 1997; 300:239-249.
30. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res. 1990;16:537-542.
31. Kim JY, Germolec DR, Luster MI. Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol. 1990;12:257-276.
32. Kim KH, Lee YS, Jung IS, Park SY, Chung HY, Lee IR, et al. Acidic polysaccharide from Panax ginseng, ginsan induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Plant Med. 1998;64:110-115.
33. Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, Yun YS. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginseng isolated from Panax ginseng. Anticancer Res. 1997;17:323-331.
34. McElhaney JE, Gravenstein S, Cole S, et al. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc. 2004;52:13-19.
35. Natural Standard (2006). Vitamin C. Available from: http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-vitaminc.html. Accessed 2008 Feb 15.
36. Harvard Medical School. Vitamin C and your health: C for crucial, C for controversial. Harvard Men's Health Watch. 2006;10(11):1-5.
37. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85-94.
38. Korant BD, Kauer JE, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature (Lond). 1974;248:588-590.
39. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol. 1976;18:298-306.
40. Kelly RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biol Reprod. 1983;28:883-889.
41. Geist FC, Bateman JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother. 1987; 31:622-624.
42. Novick SG, Godfrey JC, Godfrey NJ, Wilder HR. How does zinc modify the common cold? Med Hypoth. 1996;46:295-302.
43. Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, doublemasked, placebo-controlled clinical study of the effectiveness of zinc acetate capsules on common cold symptoms in allergy-tested subjects. Curr Ther Res. 1998;59:595-607.
44. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25:20-24.
45. Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrrell DA. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother. 1987;20:893-901.
46. Godfrey JC, Conant Sloane B, Smith DS, Turco JH, Mercer N, Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. 1992;20:234-246.